Covidien buys Power Medical Interventions
This article was originally published in The Gray Sheet
Firm will acquire Power Medical Interventions, maker of computer-assisted surgical cutting and stapling products, for about $64 million including debt, in an all-cash tender offer. The Langhorne, Pa.-based firm had 2008 revenues of $9 million. PMI's products include the SurgAssist power stapler and wireless Intelligent Surgical Instruments, such as the firm's i60 articulating endoscopic linear cutter for laparoscopic surgery. PMI also has standing agreements with Intuitive Surgical to jointly develop a novel surgical stapling device that will attach to Intuitive's da Vinci surgical system. Covidien said in a July 30 third-quarter earnings call it will honor those agreements and "look[s] forward to working with Intuitive." PMI's stock price rose 250% from $0.58 to $2.03 following the July 29 announcement. The deal is expected to close by Sept. 25. A Covidien subsidiary will pay $2.08 per share for PMI's common stock
You may also be interested in...
Covidien is adding brain monitoring technology to its lineup through the $210 million acquisition of Aspect Medical Systems, announced Sept. 28
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.